Skip to content

Comparison of Walking in Water and on Land in People With Chronic Obstructive Pulmonary Disease (COPD)

Determining the Metabolic Load of Walking in Water Compared to Walking on Land in People With COPD, Who Are Normal Weight and Obese, Compared to Peak Exercise Metabolic Response: a Prospective, Randomised Cross-over Pilot Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02757157
Enrollment
14
Registered
2016-04-29
Start date
2016-10-31
Completion date
2020-01-01
Last updated
2021-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Keywords

Hydrotherapy, Walking

Brief summary

The purpose of this study is to evaluate the metabolic load during a single session of moderate intensity walking in water compared to walking on land (over-ground) in people with chronic obstructive pulmonary disease (COPD) who are normal weight and obese, compared with peak exercise metabolic response. The hypothesis is that the metabolic load of walking at a moderate intensity in water will be greater than walking on land.

Interventions

BEHAVIORALWater-based walking

Participants will walk in the water for 15 minutes at an intensity rating of five on the modified Borg scale for dyspnoea or perceived exertion, whichever is the highest. Walking intensity will be measured every three minutes during each walking session. If the intensity level is reported as below five, participants will be encouraged to increase the intensity by increasing their walking speed. During walking in water, VO2 and VE will be measured breath-by-breath using the Oxycon mobile. Every three minutes during the walking, heart rate, oxygen saturation, dyspnoea and exertion will be measured.

BEHAVIORALLand-based walking

Participants will walk on land for 15 minutes at an intensity rating of five on the modified Borg scale for dyspnoea or perceived exertion, whichever is the highest. Walking intensity will be measured every three minutes during each walking session. If the intensity level is reported as below five, participants will be encouraged to increase the intensity by increasing their walking speed. During walking on land, VO2 and VE will be measured breath-by-breath using the Oxycon mobile. Every three minutes during the walking, heart rate, oxygen saturation, dyspnoea and exertion will be measured.

Sponsors

Center for Integrated Rehabilitation and Organ Failure Horn
CollaboratorOTHER
European Respiratory Society
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosis of COPD (FEV1/FVC \<0.7) in a clinically stable state (no acute exacerbation of COPD within the previous 4 weeks) * accepting of walking in water * BMI \>/= 21 kg/m2

Exclusion criteria

* long-term oxygen therapy * contraindications to entering a hydrotherapy pool

Design outcomes

Primary

MeasureTime frame
Breath-by-breath oxygen consumption (VO2)Day of assessment during study measurement period (15 minutes)

Secondary

MeasureTime frame
Minute ventilation (VE)Day of assessment during study measurement period (15 minutes)

Other

MeasureTime frame
Dyspnoea, measured by the modified Borg 0-10 category ratio scaleDay of assessment during study measurement period (15 minutes)
Exertion, measured by the modified Borg 0-10 category ratio scaleDay of assessment during study measurement period (15 minutes)
Oxygen saturationDay of assessment during study measurement period (15 minutes)
Heart rateDay of assessment during study measurement period (15 minutes)

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026